Ocumension

Beyond's analysis on Ocumension

• 2026-08-10 — Ocumension files NDA in China for Nicox’s NCX 470 glaucoma therapy, marking a key regulatory milestone for the ophthalmic asset

Recent news mentioning Ocumension

• 2026-08-10 — Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
• 2026-08-10 — Nicox annonce la soumission d’une NDA pour NCX 470 en Chine par son partenaire Ocumension

Appears alongside

• NDA
• NCX
• Chine

Browse the full archive →